U.S. vaccine panel recommends GSK's Rotarix

06/26/2008 | Bloomberg

The U.S. Advisory Committee on Immunization Practices on Wednesday approved the inclusion of Rotarix, GlaxoSmithKline PLC's rotavirus vaccine, in the list of recommended childhood immunizations. The vaccine, co-developed with Avant Immunotherapeutics, is expected to compete against Merck & Co.'s RotaTeq.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations